Literature DB >> 911839

Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes.

B Munch-Petersen, G Tyrsted.   

Abstract

Thymidine kinase (ATP:thymidine 5'-phosphotransferase, EC 2.7.1.21) activity increased approx. 200-fold during transformation of human lymphocytes with phytohaemagglutinin. Two peaks of thymidine kinase (peak IS and peak IIS) were separated from stimulated lymphocytes on DEAE-Sephadex. The activity in peak IS was 20-fold the activity in peak IIS. Only one peak was obtained from normal lymphocytes (peak IIN). The elution volume of this peak was identical to that of peak IIS. The Km values for ATP were 1 mM for peak IS, 0.2 mM for peak IIS and 0.3 mM for peak IIN. 90 micronM dTTP gave 50% inhibition of the activity in peak IS, while the same inhibition of the activities in peak IIS and peak IIN was obtained with only 15 micronM dTTP. Km for thymidine was about 6 micronM for peak IS. The kinetic relation between thymidine and the activity in peak IIS was complex but very similar to that of peak IIN. It is suggested, that a new form of thymidine kinase appears in the lymphocytes due to phytohaemagglutinin stimulation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911839     DOI: 10.1016/0005-2787(77)90152-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Structures of thymidine kinase 1 of human and mycoplasmic origin.

Authors:  Martin Welin; Urszula Kosinska; Nils-Egil Mikkelsen; Cecilia Carnrot; Chunying Zhu; Liya Wang; Staffan Eriksson; Birgitte Munch-Petersen; Hans Eklund
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination.

Authors:  M Merkenschlager; D Kardamakis; F C Rawle; N Spurr; P C Beverley
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  Effect of the benzene fraction of petroleum on thymidine kinase activity and DNA content in rat liver and kidney.

Authors:  M Bong-Mastek; T Laskowska-Klita; T Szymczyk
Journal:  Bull Environ Contam Toxicol       Date:  1986-07       Impact factor: 2.151

4.  Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells.

Authors:  D R Gewert; G Moore; M J Clemens
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

5.  Effect of 5-fluoro-2'-deoxyuridine and hydroxyurea on the phytohemagglutinin-induced increase of thymidine kinase, replicative DNA polymerase, deoxycytidylate deaminase and CDP reductase activities in human lymphocytes.

Authors:  G Tyrsted
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

6.  Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes.

Authors:  B Munch-Petersen
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

7.  Human thymidine kinase: purification and some properties of the TK1 isoenzyme from placenta.

Authors:  P H Ellims; T E Gan; L Cosgrove
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

8.  Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.

Authors:  D L Francis; D Visvikis; D C Costa; T H A Arulampalam; C Townsend; S K Luthra; I Taylor; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-09       Impact factor: 9.236

9.  Isotope-dilution analysis of the effects of deoxyguanosine and deoxyadenosine on the incorporation of thymidine and deoxycytidine by hydroxyurea-treated thymus cells.

Authors:  F W Scott; D R Forsdyke
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

10.  Thymidine kinase isoenzymes in human acute monocytic leukemia.

Authors:  B Munch-Petersen; G Tyrsted
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.